Erik Henricson

6.9k total citations
70 papers, 2.4k citations indexed

About

Erik Henricson is a scholar working on Molecular Biology, Psychiatry and Mental health and Developmental and Educational Psychology. According to data from OpenAlex, Erik Henricson has authored 70 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 12 papers in Psychiatry and Mental health and 12 papers in Developmental and Educational Psychology. Recurrent topics in Erik Henricson's work include Muscle Physiology and Disorders (58 papers), Children's Physical and Motor Development (12 papers) and Cerebral Palsy and Movement Disorders (12 papers). Erik Henricson is often cited by papers focused on Muscle Physiology and Disorders (58 papers), Children's Physical and Motor Development (12 papers) and Cerebral Palsy and Movement Disorders (12 papers). Erik Henricson collaborates with scholars based in United States, United Kingdom and Canada. Erik Henricson's co-authors include Craig M. McDonald, Richard T. Abresch, Julaine Florence, Jay J. Han, Gary Elfring, A. Reha, Alina Nicorici, Diana M. Escolar, Paula R. Clemens and Eric P. Hoffman and has published in prestigious journals such as PLoS ONE, Neurology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Erik Henricson

68 papers receiving 2.4k citations

Peers

Erik Henricson

GENET

CCM

PMH

Donovan J. Lott United States

S. Pandya United States

Linda Lowes United States

Brenda Wong United States

Valeria Ricotti United Kingdom

Sonia Messina Italy

Anna Mayhew United Kingdom

Marion Main United Kingdom

Lisa S. Krivickas United States

Eduard Gappmaier United States

Donovan J. Lott United States

Erik Henricson

1.2k ×0.7

680 ×1.4

193 ×0.4

GENET

330 ×0.9

CCM

159 ×0.4

PMH

Citations per year, relative to Erik Henricson Erik Henricson (= 1×) peers Donovan J. Lott

Countries citing papers authored by Erik Henricson

Since Specialization

Citations

This map shows the geographic impact of Erik Henricson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Henricson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Henricson more than expected).

Fields of papers citing papers by Erik Henricson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Henricson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Henricson. The network helps show where Erik Henricson may publish in the future.

Co-authorship network of co-authors of Erik Henricson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Henricson. A scholar is included among the top collaborators of Erik Henricson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Henricson. Erik Henricson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Xin, Chen‐Nee Chuah, Erica Goude, et al.. (2024). Gait Event Detection and Travel Distance Using Waist-Worn Accelerometers across a Range of Speeds: Automated Approach. Sensors. 24(4). 1155–1155. 3 indexed citations

Liu, Xin, Erica Goude, Jiahui Hou, et al.. (2024). Gait Characterization in Duchenne Muscular Dystrophy (DMD) Using a Single-Sensor Accelerometer: Classical Machine Learning and Deep Learning Approaches. Sensors. 24(4). 1123–1123. 7 indexed citations

Rocha, Carolina Tesi, et al.. (2024). Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study. Advances in Therapy. 41(8). 3278–3298. 3 indexed citations

Mercuri, Eugenio, A. Nascimento Osorio, Francesco Muntoni, et al.. (2023). Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis. Journal of Neurology. 270(8). 3896–3913. 21 indexed citations

Muntoni, Francesco, et al.. (2022). POSA353 Conceptual Models of the Patient Experience of Duchenne Muscular Dystrophy Constructed from a Qualitative Interview Study with Caregivers. Value in Health. 25(1). S218–S218. 2 indexed citations

Batra, Abhinandan, Donovan J. Lott, Rebecca J. Willcocks, et al.. (2022). Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging. BMC Cardiovascular Disorders. 22(1). 260–260. 10 indexed citations

Tuttle, Edward, et al.. (2022). Disease Progression Stages and Burden in Patients with Duchenne Muscular Dystrophy Using Administrative Claims Supplemented by Electronic Medical Records. Advances in Therapy. 39(6). 2906–2919. 13 indexed citations

Duong, Tina, Marisa Birkmeier, Leslie Nelson, et al.. (2021). The Minimal Clinical Important Difference (MCID) in Annual Rate of Change of Timed Function Tests in Boys with DMD. Journal of Neuromuscular Diseases. 8(6). 939–948. 13 indexed citations

Khan, Navid, Helen Eliopoulos, Lixin Han, et al.. (2019). Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases. 6(2). 213–225. 67 indexed citations

10.

Finder, Jonathan D., Oscar H. Mayer, Daniel W. Sheehan, et al.. (2017). Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary. American Journal of Respiratory and Critical Care Medicine. 196(4). 512–519. 33 indexed citations

11.

Mayer, Oscar H., Erik Henricson, Craig M. McDonald, & Gunnar Buyse. (2017). Advances in Pulmonary Care in Duchenne Muscular Dystrophy. 13(1). 35–35. 14 indexed citations

12.

Boca, Simina M., Michael A. Harris, Shruti Rao, et al.. (2016). Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study. PLoS ONE. 11(4). e0153461–e0153461. 31 indexed citations

13.

Hathout, Yetrib, Laurie S. Conklin, Haeri Seol, et al.. (2016). Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children. Scientific Reports. 6(1). 31727–31727. 36 indexed citations

14.

Bello, Luca, Heather Gordish‐Dressman, Avital Cnaan, et al.. (2015). Genetic modifiers of ambulation in the CINRG duchenne natural history study.. Annals of Neurology. 3 indexed citations

15.

Bello, Luca, Heather Gordish‐Dressman, Lauren P. Morgenroth, et al.. (2015). Prednisone/prednisolone and deflazacort differ in long term outcomes on ambulation and side effects in the CINRG Duchenne Natural History Study (S50.001). Neurology. 84(14_supplement). 2 indexed citations

16.

Henricson, Erik, Richard T. Abresch, Avital Cnaan, et al.. (2013). The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures. Muscle & Nerve. 48(1). 55–67. 135 indexed citations

17.

McDonald, Craig M., Erik Henricson, Richard T. Abresch, et al.. (2013). The cooperative international neuromuscular research group duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used. Muscle & Nerve. 48(1). 32–54. 116 indexed citations

18.

McDonald, Craig M., Erik Henricson, Richard T. Abresch, et al.. (2013). The 6‐minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle & Nerve. 48(3). 357–368. 235 indexed citations

19.

Zimmerman, Andrew, Paula R. Clemens, Carolina Tesi Rocha, et al.. (2011). Liquid formulation of pentoxifylline is a poorly tolerated treatment for duchenne dystrophy. Muscle & Nerve. 44(2). 170–173. 5 indexed citations

20.

Escolar, Diana M., Carolina Tesi Rocha, Paula R. Clemens, et al.. (2007). G.P.9.09 Immediate release oral pentoxifylline is poorly tolerated in Duchenne muscular dystrophy boys. Neuromuscular Disorders. 17(9-10). 817–817. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact